Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2.
作者信息
Humbert Olivier, Laszlo George S, Sichel Sophie, Ironside Christina, Haworth Kevin G, Bates Olivia M, Beddoe Mary E, Carrillo Ray R, Kiem Hans-Peter, Walter Roland B
机构信息
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
出版信息
Leukemia. 2019 Mar;33(3):762-808. doi: 10.1038/s41375-018-0277-8. Epub 2018 Oct 5.
PMID:30291334
Abstract
摘要
Zotero 插件